Capstone Investment Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.2M | Buy |
118,200
+49,000
| +71% | +$4.69M | 0.02% | 277 |
|
|
2025
Q4 | $6.65M | Sell |
69,200
-80,200
| -54% | -$7.79M | 0.01% | 322 |
|
|
2025
Q3 | $14.2M | Buy |
149,400
+39,100
| +35% | +$3.59M | 0.03% | 257 |
|
|
2025
Q2 | $9.61M | Sell |
110,300
-15,400
| -12% | -$1.31M | 0.02% | 256 |
|
|
2025
Q1 | $11.3M | Sell |
125,700
-90,300
| -42% | -$8.08M | 0.03% | 265 |
|
|
2024
Q4 | $17.3M | Buy |
216,000
+60,500
| +39% | +$5.24M | 0.04% | 242 |
|
|
2024
Q3 | $14M | Sell |
155,500
-2,600
| -2% | -$219K | 0.04% | 241 |
|
|
2024
Q2 | $12.4M | Buy |
158,100
+12,600
| +9% | +$1.03M | 0.04% | 269 |
|
|
2024
Q1 | $12.7M | Sell |
145,500
-83,900
| -37% | -$7.16M | 0.05% | 236 |
|
|
2023
Q4 | $18.9M | Buy |
229,400
+87,300
| +61% | +$6.65M | 0.06% | 216 |
|
|
2023
Q3 | $11.1M | Buy |
142,100
+50,000
| +54% | +$4.19M | 0.05% | 259 |
|
|
2023
Q2 | $8.11M | Buy |
92,100
+20,300
| +28% | +$1.75M | 0.04% | 281 |
|
|
2023
Q1 | $5.79M | Buy |
71,800
+42,600
| +146% | +$3.47M | 0.03% | 336 |
|
|
2022
Q4 | $2.27M | Sell |
29,200
-147,000
| -83% | -$11.9M | 0.02% | 666 |
|
|
2022
Q3 | $14.2M | Buy |
176,200
+4,600
| +3% | +$413K | 0.09% | 162 |
|
|
2022
Q2 | $15.4M | Sell |
171,600
-307,600
| -64% | -$31.2M | 0.08% | 174 |
|
|
2022
Q1 | $53.2M | Sell |
479,200
-716,800
| -60% | -$75.7M | 0.15% | 104 |
|
|
2021
Q4 | $124M | Buy |
1,196,000
+130,200
| +12% | +$15.1M | 0.21% | 90 |
|
|
2021
Q3 | $134M | Sell |
1,065,800
-49,400
| -4% | -$6.39M | 0.26% | 72 |
|
|
2021
Q2 | $138M | Buy |
1,115,200
+81,800
| +8% | +$10.3M | 0.31% | 68 |
|
|
2021
Q1 | $122M | Buy |
1,033,400
+278,400
| +37% | +$32.6M | 0.36% | 54 |
|
|
2020
Q4 | $88.4M | Buy |
755,000
+395,000
| +110% | +$43.5M | 0.3% | 55 |
|
|
2020
Q3 | $37.4M | Buy |
360,000
+123,000
| +52% | +$12.4M | 0.19% | 94 |
|
|
2020
Q2 | $21.7M | Buy |
237,000
+82,900
| +54% | +$7.95M | 0.14% | 132 |
|
|
2020
Q1 | $13.9M | Sell |
154,100
-391,900
| -72% | -$41.7M | 0.22% | 80 |
|
|
2019
Q4 | $61.9M | Buy |
546,000
+102,000
| +23% | +$11.2M | 0.33% | 54 |
|
|
2019
Q3 | $48.2M | Buy |
444,000
+94,800
| +27% | +$9.89M | 0.33% | 59 |
|
|
2019
Q2 | $34M | Buy |
349,200
+109,900
| +46% | +$10M | 0.25% | 93 |
|
|
2019
Q1 | $21.8M | Buy |
239,300
+100,900
| +73% | +$9.03M | 0.2% | 111 |
|
|
2018
Q4 | $12.6M | Buy |
138,400
+27,500
| +25% | +$2.57M | 0.16% | 107 |
|
|
2018
Q3 | $10.9M | Buy |
110,900
+78,800
| +245% | +$7.29M | 0.12% | 134 |
|
|
2018
Q2 | $2.75M | Buy |
32,100
+29,400
| +1,089% | +$2.46M | 0.04% | 237 |
|
|
2018
Q1 | $217K | Buy |
+2,700
| New | +$223K | ﹤0.01% | 300 |
|
|
2017
Q2 | – | Sell |
-15,200
| Closed | -$1.22M | – | 814 |
|
|
2017
Q1 | $1.22M | Sell |
15,200
-6,300
| -29% | -$492K | 0.03% | 377 |
|
|
2016
Q4 | $1.53M | Buy |
+21,500
| New | +$1.69M | 0.05% | 337 |
|
|
2015
Q2 | – | Sell |
-44,700
| Closed | -$3.49M | – | 320 |
|
|
2015
Q1 | $3.49M | Buy |
44,700
+26,900
| +151% | +$2.04M | 0.06% | 170 |
|
|
2014
Q4 | $1.28M | Sell |
17,800
-8,200
| -32% | -$570K | 0.02% | 248 |
|
|
2014
Q3 | $1.61M | Buy |
+26,000
| New | +$1.65M | 0.02% | 308 |
|
|
2013
Q4 | – | Sell |
-60,000
| Closed | -$3.19M | – | 530 |
|
|
2013
Q3 | $3.19M | Buy |
+60,000
| New | +$3.23M | 0.03% | 263 |
|
Other funds holding MDT
VCM
VPM
Capstone Investment Advisors's MDT Position: Q1 2026 in Review
Capstone Investment Advisors opened a new position in Medtronic (MDT) in Q1 2026: 17,830 shares worth $1.54M. The stake represents ﹤0.01% of the portfolio and ranks #714 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in MDT as recently as Q3 2025.
Capstone Investment Advisors first reported a position in MDT in Q1 2015 and has held it in 28 quarters since. The position peaked at $51M in Q4 2021. 2,232 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Capstone Investment Advisors held 17,830 shares of Medtronic worth $1.54M as of Q1 2026.
- Medtronic was a new Capstone Investment Advisors position in Q1 2026.
- Medtronic made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #714 holding.
- Capstone Investment Advisors first reported a position in Medtronic in Q1 2015 and has held it in 28 quarters since.
- Capstone Investment Advisors's Medtronic position peaked at $51M in Q4 2021.
- 2,232 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.